Ardelyx (ARDX) Free Cash Flow (2013 - 2026)
Ardelyx (ARDX) posted Free Cash Flow of -$32.3 million for Q1 2026, down 256.9% on a QoQ basis from $20.6 million in Q4 2025, and up 16.7% year-over-year from -$27.7 million in Q1 2025.
Ardelyx (ARDX) Free Cash Flow (2013 - 2026) Analysis & Trends
Ardelyx's Free Cash Flow history runs 14 years deep, the most recent figure standing at -$32.3 million for Q1 2026.
- Quarterly Free Cash Flow rose 16.7% year-over-year to -$32.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.5 million (up 23.05% YoY) and the FY2025 annual result came in at -$44.0 million, up 4.03% from the prior year.
- Free Cash Flow was -$32.3 million for Q1 2026 at Ardelyx, down from $20.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $20.6 million in Q4 2025 and bottomed at -$44.8 million in Q1 2023.
- A 5-year average of -$16.6 million and a median of -$21.7 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow sank 161.57% — and 2024, when it jumped 205.2%.
- Ardelyx's Free Cash Flow stood at $14.2 million in 2022, then sank by 161.57% to -$8.8 million in 2023, then soared by 205.2% to $9.2 million in 2024, then surged by 123.39% to $20.6 million in 2025, then tumbled by 256.9% to -$32.3 million in 2026.
- Business Quant data shows ARDX's Free Cash Flow at -$32.3 million in Q1 2026, $20.6 million in Q4 2025, and $209000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -32.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.31 Mn |
| Mar 31, 2026 | -32.31 Mn |
| Dec 31, 2025 | 20.59 Mn |
| Dec 31, 2025 | 20.59 Mn |
| Sep 30, 2025 | 209,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Jun 30, 2025 | -25.99 Mn |
| Jun 30, 2025 | -25.99 Mn |
| Mar 31, 2025 | -38.78 Mn |
| Mar 31, 2025 | -38.78 Mn |
| Dec 31, 2024 | 9.22 Mn |
| Dec 31, 2024 | 9.22 Mn |
| Sep 30, 2024 | 364,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Jun 30, 2024 | -19.53 Mn |
| Jun 30, 2024 | -19.53 Mn |
| Mar 31, 2024 | -35.87 Mn |
| Mar 31, 2024 | -35.87 Mn |
| Dec 31, 2023 | -8.76 Mn |
| Dec 31, 2023 | -8.76 Mn |